Multiple Sclerosis in the Elderly: Epidemiology, Clinical and MRI Characteristics (OLDMUS)
Little is known about old MS patients. In a previous work, systematic search in Bordeaux, Strasbourg and Dijon university hospital regional MS center databases European Database for Multiple Sclerosis (EDMUS) retrieved 2% of 75 years old or older Multiple Sclerosis (MS) patients in the 3 databases. Data analysis showed that MS may switch off in the very old patients with mild progression and very few relapses. The project is to continue this preliminary work and extend it with a systematic study of MS in the elderly.
The scientific aims: To add new insights into long lasting MS natural history in the growing population of elderly patients with MS.
研究概览
地位
条件
详细说明
75 to 77 years old MS patients whose disease began at 65 years old or earlier will be retrieved from the "Observatoire français de la sclérose en plaques" (OFSEP) which includes more than 50 000 MS patients in France. Accuracy of these patients' data from 65 to 75 years old will be thereafter checked and completed in 3 French MS centers: Lyon, Rennes and Bordeaux, participating to this database directly from the patients' clinical files. From these 3 MS centers around 150 MS patients from 75 to 77 years old are expected to be analysed on site.
The data wich will be retrieved for these patients are: irreversible disability status scale progression, relapses, Magnetic Resonance Imaging (MRI) data, CSF data, Lublin classification of type of MS, McDonald 2005 and 2010 criteria, date and age at beginning of progression, characteristics and modality of relapses and clinical impairment at the beginning of the disease, treatments used, treatment failures and side effects, co morbidity, Barthel index, EuroQol-5D (EQ-5D), cognitive impairment (SDMT test), social life data and socio economic data. To the investigator's knowledge this will be the first systematic description of very old MS patients with data on long term natural history of MS and characteristics in this population of elderly MS patients.
研究类型
注册 (实际的)
联系人和位置
学习地点
-
-
-
Bordeaux、法国
- CHU de Bordeaux - Pellegrin - service de neurologie
-
Bron、法国
- Hôpital neurologique - Pierre Wertheimer
-
Rennes、法国
- CHU de Rennes - service de neurologie
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
描述
Inclusion Criteria:
- Patients with McDonald 2001, 2005 or 2010 criteria of multiple sclerosis 75 to 77 years old MS patients at the time of inclusion
- Patients whose beginning of MS was before 65 years old or 65 years old
- Patients who signed OFSEP 's consent
Exclusion Criteria:
- Patients whose clinical data cannot be entered or for whom too much clinical data are missing
- Alive patients older than 77 years or younger than 75 years the day of the inclusion in the study
- Patients died before 65 years old
学习计划
研究是如何设计的？
设计细节
队列和干预
团体/队列 |
|---|
|
Old MS patients
75 to 77 years old MS patients whose disease began at 65 years old or earlier will be retrieved from the "Observatoire français de la sclérose en plaques" (OFSEP).
|
研究衡量的是什么？
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Evaluation of MS evolution with disability progression (irreversible Disability Status Scale) in 75 to 77 years Old MS Patients from the age of 65 years-old to present time
大体时间：At inclusion (day 0)
|
Time to reach the irreversible Kurtzke disability status scale (DSS) score 4, 6 and 7
|
At inclusion (day 0)
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Frequency of clinical relapses in 75 years Old or Older MS Patients from the age of 65 years-old to present time
大体时间：At inclusion (day 0)
|
At inclusion (day 0)
|
|
|
Description of the clinical characteristics at 75 years Old
大体时间：At inclusion (day 0)
|
Clinical conversion to secondary progressive MS date
|
At inclusion (day 0)
|
|
Description of the Cerebral MRI at 75 years Old
大体时间：At inclusion (day 0)
|
Number of lesions on T2 sequence if <9, number of new T2 lesions, Number of Gadolinium enhancing lesions, T1-Hypointense Lesions (T1 Black Holes), MRI Barkhof Criteria and number of periventricular lesions if <3,
|
At inclusion (day 0)
|
|
Description of the paraclinical characteristics at 75 years Old
大体时间：At inclusion (day 0)
|
Distance walked (with or without help)
|
At inclusion (day 0)
|
|
Description of the paraclinical characteristics at 75 years Old
大体时间：At inclusion (day 0)
|
Barthel index
|
At inclusion (day 0)
|
|
Socio-demographic data
大体时间：At inclusion (day 0)
|
sex
|
At inclusion (day 0)
|
|
Socio-demographic data
大体时间：At inclusion (day 0)
|
age
|
At inclusion (day 0)
|
|
Socio-demographic data
大体时间：At inclusion (day 0)
|
department of residence
|
At inclusion (day 0)
|
|
Description of the treatments at 75 years Old
大体时间：At inclusion (day 0)
|
Treatments of multiple sclerosis
|
At inclusion (day 0)
|
|
Description of the treatments at 75 years Old
大体时间：At inclusion (day 0)
|
Failures treatments of multiple sclerosis
|
At inclusion (day 0)
|
|
Description of the treatments at 75 years Old
大体时间：At inclusion (day 0)
|
Side effects of treatments and other concomitant treatments
|
At inclusion (day 0)
|
|
Measure of health-related quality of life at 75 years Old
大体时间：At inclusion (day 0)
|
EQ-5D Instruments
|
At inclusion (day 0)
|
|
Evaluation of cognitive functions at 75 years Old
大体时间：At inclusion (day 0)
|
Symbol digit modalities test (SDMT) test
|
At inclusion (day 0)
|
合作者和调查者
调查人员
- 首席研究员：Jean-Christophe OUALLET, MD, PhD、CHU de Bodeaux
- 学习椅：Sandra VUKUSIC, Prof.、Observatoire Français de la sclérose en plaques (OFSEP)
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.